InvestorsHub Logo
Followers 3
Posts 231
Boards Moderated 0
Alias Born 07/28/2011

Re: GrthzGd post# 15562

Monday, 05/09/2016 2:40:34 PM

Monday, May 09, 2016 2:40:34 PM

Post# of 20689
Don't lump Baxter in with Amphastar.

Baxter, now spin-off Baxalta, and likely soon to become Shire is a JV partner on M923 (humira).

Its tough to keep straight with the mergers but I think it's Amphastar and Watson/Actavis now Allergan.

And the bond was $100 million of which MNTA's share was $30m.